Table 1.
Baseline patient characteristics (demographics and disease characteristics).
| Variables | Ferric Carboxymaltose group |
|---|---|
| Age (years), median, IQRa | 66 ± 16 |
| Gender, n (%) | |
| Male | 49 (49.5) |
| Female | 50 (50.5) |
| Cancer type, n (%) | |
| Colorectal | 22 (22.2) |
| Gastric | 22 (22.2) |
| Breast | 21 (21.2) |
| Pancreas | 11 (11.1) |
| Gynaecological | 7 (7.1) |
| Lung | 4 (4.1) |
| Othersb | 12 (12.1) |
| Disease stage at diagnosis, n (%) | |
| I-III | 60 (60.6) |
| IV | 39 (39.4) |
| Intention treatment at inclusion, n (%) | |
| Curative | 45 (45.5) |
| Palliative | 54 (54.5) |
| Ongoing chemotherapy at inclusion, n (%) | 94 (94.9%) |
| Iron Deficiency, n (%) | |
| Absolute | 18 (18.2) |
| Relative | 81 (81.8) |
aAbbreviations: IQR – interquartile range.
bOthers: head and neck, cholangiocarcinoma, oesophagus, occult primary tumour, urothelial.